NCT04796948View on ClinicalTrials.gov

A Study of Irinotecan Liposome in Advanced Pancreatic Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

April 8, 2021

Primary Completion Date

June 28, 2024

Study Completion Date

June 28, 2024

Conditions
Advanced Pancreatic Cancer
Interventions
DRUG

Irinotecan liposome；oxaliplatin；5-FU(Fluorouracil Injection)；LV(Calcium Folinate Injection)

irinotecan liposome in combination with oxaliplatin and 5-FU/LV

Trial Locations (1)

100730

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY